Information about treasury shares

SOPHARMA AD hereby informs that from 18 December 2014 up to and including 7 January 2015 the Company bought 3897 own shares representing 0.003% of the share capital of the Company, to the total value of 15 019.98 BGN on the Bulgarian Stock Exchange, the average price per share was 3.85 BGN.

The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010.

The total number of treasury shares after these transactions is 5 117 450, representing 3.88% of the share capital of the Company.

Polski

EGM - 9 January 2015

We would hereby like to notify that the Extraordinary General Meeting of Shareholders of Sopharma AD held on January 9, 2015 in Sofia took a decision for trnasformation of Sopharma AD throught the merger of Bulgarian Rose – Sevtopolis AD based in the city of Kazanlak, UIC 123007916. As a result the whole property of Bulgarian Rose – Sevtopolis AD will be transferred to Sopharma AD with the full rights.

Polski

Information about treasury shares

SOPHARMA AD hereby informs that from 8 January 2015 up to and including 14 January 2015 the Company bought 2 677 own shares representing 0.002% of the share capital of the Company, to the total value of 9 957.10 BGN on the Bulgarian Stock Exchange, the average price per share was 3.72 BGN.

The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010.

The total number of treasury shares after these transactions is 5 120 127, representing 3.88% of the share capital of the Company.

Polski

Information about treasury shares

SOPHARMA AD hereby informs that from 15 January 2015 up to and including 21 January 2015 the Company bought 1 000 own shares representing 0.00076% of the share capital of the Company, to the total value of 3 720.00 BGN on the Bulgarian Stock Exchange, the average price per share was 3.72 BGN.

The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010.

The total number of treasury shares after these transactions is 5 121 127, representing 3.88% of the share capital of the Company.

Polski

Information about treasury shares

SOPHARMA AD hereby informs that from 10 February 2015 up to and including 13 February 2015 the Company bought 10 500 own shares representing 0.0080% of the share capital of the Company, at a total value of 37 792 BGN on the Bulgarian Stock Exchange, the average price per share was 3.599 BGN.

The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010.

The total number of treasury shares after these transactions is 5 136 521, representing 3.89% of the share capital of the Company.

Polski

EGM

The Board of Directors of Sopharma AD (the “Company”) hereby notifies that the Invitation to the Extraordinary Meeting of Shareholders of “Sopharma” AD, which will take place on 1 November 2012 at 11:00, and in the absence of a quorum – on 15 November 2012 at 11:00 in Sofia, 16 “Iliensko shose” Str., has been registered in the Commercial Register under number 20120925101646.

Polski

Information about treasury shares

The Board of Directors of SOPHARMA AD (the “Company”) hereby informs that from 13 September 2012 up to and including 19 September 2012 the Company bought 550 own shares representing 0.00042% of the share capital of the Company, to the total value of BGN 1330.00 on the Bulgarian Stock Exchange. The average price per share was BGN 2.418.

The shares have been bought on the basis of the general meeting resolution No. 7 of 23.06.2010.

Polski

Information about treasury shares

The Board of Directors of SOPHARMA AD (the “Company”) hereby informs that from 13 September 2012 up to and including 19 September 2012 the Company bought 550 own shares representing 0.00042% of the share capital of the Company, to the total value of BGN 1330.00 on the Bulgarian Stock Exchange. The average price per share was BGN 2.418.

The shares have been bought on the basis of the general meeting resolution No. 7 of 23.06.2010.

Polski

Sales revenues for January 2015

Sopharma AD notifies that for January 2015 the Company recorded a decrease of sales revenues of 43% compared to the same month of 2014, including 11% increase of domestic sales and 61% decrease of export sales. 

The volatility of the RUB caused us to undertake actions to adjust the prices for our main export market - Russia, which prevented us from exporting during the period. Our forecast is that this slow down in the beginning of the year will be compensated already in the first quarter.

Polski

Information about treasury shares

SOPHARMA AD hereby informs that from 29 January 2015 up to and including 4 February 2015 the Company bought 3 200 own shares representing 0.0024% of the share capital of the Company, at a total value of 11 534.90 BGN on the Bulgarian Stock Exchange, the average price per share was 3.605 BGN.

The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010.

The total number of treasury shares after these transactions is 5 126 021, representing 3.88% of the share capital of the Company.

Polski

Strony